SCHEMBL462461

SCHEMBL462461

C=CCN(CC=C)c1ccc2ccc(=O)oc2c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.65
▸ ALDH1A1 P00352 5/20 0.65
▸ GLA P06280 3/20 0.65
▸ L3MBTL1 Q9Y468 1/20 0.65
▸ CA12 O43570 9/20 0.52
▸ CA9 Q16790 9/20 0.52
▸ CA1 P00915 8/20 0.52
▸ SRD5A1 P18405 2/20 0.51
▸ HPGD P15428 4/20 0.45
▸ AKR1B1 P15121 3/20 0.45
▸ HSD17B10 Q99714 3/20 0.45
▸ MCL1 Q07820 3/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ GAA P10253 2/20 0.45
▸ CASP1 P29466 2/20 0.45
▸ CASP7 P55210 2/20 0.45
▸ ERAP1 Q9NZ08 2/20 0.45
▸ TDP1 Q9NUW8 2/20 0.45
▸ PGR P06401 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formaldehyde SCHEMBL28369375 0.79 ALDH1A1 (0.94) KDM4EALDH1A1GLAL3MBTL1CA12
SCHEMBL142022 0.79 ALDH1A1 (1.00) KDM4EALDH1A1GLAL3MBTL1CA12
SCHEMBL29440642 0.79 ALDH1A1 (1.00) KDM4EALDH1A1GLAL3MBTL1CA12
SCHEMBL17145062 0.79 MEN1 (0.71) KDM4EALDH1A1GLAL3MBTL1HPGD
SCHEMBL8813329 0.79 IGLV6-57 (0.47) KDM4EALDH1A1GLAL3MBTL1SRD5A1
SCHEMBL16296942 0.78 ALDH1A1 (0.49) KDM4EALDH1A1GLAL3MBTL1CA12
Bromide SCHEMBL31261167 0.78 ALDH1A1 (0.97) KDM4EALDH1A1GLAL3MBTL1CA12
SCHEMBL3950391 0.77 ALDH1A1 (0.68) KDM4EALDH1A1GLAL3MBTL1CA12
SCHEMBL1752667 0.77 ALDH1A1 (0.70) KDM4EALDH1A1GLAL3MBTL1CA12
SCHEMBL15138689 0.76 SLC16A3 (0.70) KDM4EALDH1A1CA12CA9CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11965881-B2 Nanosensors and methods for detection of biological markers KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) 2024-04-23 — — US disclosed
US-20240125800-A1 NANOSENSORS FOR RAPID IDENTIFICATION OF LUNG CONDITIONS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2024-04-18 — — US disclosed
US-11952612-B2 Protease sensor molecules COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2024-04-09 — — US disclosed
WO-2024010609-A1 PRISTINE GRAPHENE BASED BIOSENSOR FOR BIOMARKER DETECTION AND RELATED CORE PARTICLES, MATERIALS COMPOSITIONS METHODS AND SYSTEMS HAWKEYE BIO, LIMITED (IE) 2024-01-11 — — WO disclosed
EP-3538665-B1 PROTEASE SENSOR MOLECULES PPB TECH PTY LTD (AU) 2024-01-03 — — EP disclosed
EP-4271651-A1 PRISTINE GRAPHENE BASED BIOSENSOR FOR BIOMARKER DETECTION AND RELATED CORE PARTICLES, MATERIALS COMPOSITIONS METHODS AND SYSTEMS HAWKEYE BIO, LIMITED (IE) 2023-11-08 — — EP disclosed
US-20230258640-A1 PRISTINE GRAPHENE BASED BIOSENSOR FOR BIOMARKER DETECTION AND RELATED CORE PARTICLES, MATERIALS COMPOSITIONS METHODS AND SYSTEMS HAWKEYE BIO, LIMITED (IE) 2023-08-17 — — US disclosed
WO-2022147179-A1 NANOSENSORS FOR RAPID IDENTIFICATION OF LUNG CONDITIONS KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) 2022-07-07 — — WO disclosed
WO-2022147171-A1 PRISTINE GRAPHENE BASED BIOSENSOR FOR BIOMARKER DETECTION AND RELATED CORE PARTICLES, MATERIALS COMPOSITIONS METHODS AND SYSTEMS HAWKEYE BIO, LIMITED (US) 2022-07-07 — — WO disclosed
US-11318470-B2 Microfluidics-based nanobiosensors and devices KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) 2022-05-03 — — US disclosed
US-20120157824-A1 MRI AND OPTICAL ASSAYS FOR PROTEASES NANOSCALE CORPORATION (US) 2012-06-21 — — US disclosed
WO-2012050896-A2 PROTEASE SELECTIVE SUPRAMOLECULAR ASSEMBLIES KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) 2012-04-19 — — WO disclosed
WO-2012034061-A2 COMBINATION METHODS OF DIAGNOSING CANCER IN A PATIENT TRAXXSSON, LLC (US) 2012-03-15 — — WO disclosed
WO-2011028698-A2 MRI AND OPTICAL ASSAYS FOR PROTEASES KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-03-10 — — WO disclosed
US-20110014125-A1 PROTEASE ASSAY KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-01-20 — — US disclosed
EP-2260108-A2 PROTEASE ASSAY Kansas State University Research Foundation (US) 2010-12-15 — — EP disclosed
US-20100040978-A1 PHOTOSENSITIVE LITHOGRAPHIC PRINTING PLATE MATERIAL KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2010-02-18 — — US disclosed
WO-2009111470-A2 PROTEASE ASSAY KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) 2009-09-11 — — WO disclosed
US-6844136-B1 Photopolymerizable mixture and recording material prepared therewith AGFA-GEVAERT (BE) 2005-01-18 — — US disclosed
EP-1079276-A1 Photopolymerisable mixture and recording material prepared therewith AGFA-GEVAERT naamloze vennootschap (BE) 2001-02-28 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110014125-A1 PROTEASE ASSAY PREP, TMPRSS15, PRSS3 KDM4E 3846/4885ALDH1A1 3771/4885GLA 318/4885
US-20120157824-A1 MRI AND OPTICAL ASSAYS FOR PROTEASES PREP, HPN, ADAM9 KDM4E 4459/4885ALDH1A1 4179/4885GLA 375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback